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Prevalence of Housing Problems Among Community
Health Center Patients
In 2016, the Health Resources and Services Administration
(HRSA) Health Center Program provided primary care to more
than 25 million medically underserved patients through a na-
tionwide network of community health center (CHC), health
care for the homeless, migrant health center, and public hous-
ing primary care clinics.1 Although the latter 3 clinic types serve
individuals with housing problems by definition, little is known
about the scope of housing problems among CHC patients, who
constitute 91% of Health Center Program patients nationally.1
We used data from a national survey to assess the prevalence
and health-related correlates of housing problems among
CHC patients.
Methods | The Partners Human Research Committee exempted
this study. We analyzed the 2014 Health Center Patient Survey,
a nationally representative, cross-sectional, in-person survey
of Health Center Program patients conducted by RTI Interna-
tional from September 2014 through April 2015 using a 3-stage
sampling design.2 First-stage sampling units were Health
Center Program grantees, stratified by funding stream, sub-
stratified by other characteristics, and sampled with probabil-
ity proportional to size. Second-stage sampling units were
clinic sites within grantees. Third-stage sampling units were pa-
tients sampled consecutively at clinics if they had made 1 prior
visit or more within the past year; 91.4% of those eligible com-
pleted interviews. We confined our analysis to CHC patients
aged 18 years or older.
We used responses to items assessing living circum-
stances to create 5 mutually exclusive housing categories:
(1) homeless—usually slept during the past week in an emer-
gency shelter, transitional shelter, or car; anywhere outside;
or any other place not meant for habitation; (2) doubled-up—
past-week residence in a house, apartment, or room that they
did not rent or own (doubled-up individuals are considered
homeless by HRSA but not by the US Department of Housing
and Urban Development3); (3) unstably housed—past-week
residence in their own place but moved 2 or more times in the
past year4 or was unable to pay the rent or mortgage at any
time;5 (4) stably housed, previously homeless—past-week
residence in their own place without the above difficulties
but previously homeless, reflecting potential housing risk;4
and (5) stably housed, never homeless—no current or prior
housing problems.
Other variables included self-reported demographic char-
acteristics, health status indicators, and measures of health care
use and access, each defined in the Table.
We used Rao-Scott χ2 tests with a 2-sided P value of less
than .05 for significance to compare respondents with (cat-
egories 1-4) vs without (category 5) current or prior housing
problems. We examined whether those with housing prob-
lems had ever received CHC assistance in finding a place to live.
We conducted analyses in SAS (SAS Institute), version 9.4, using
strata, cluster, and weight variables to account for the sam-
pling design. Reported percentages are weighted.
Results | Of 3172 adult CHC patients, 3148 provided sufficient
information to characterize their housing status. Of these, 1.2%
(95% CI, 0.6%-1.8%) reported current homelessness, 9.0%
(95% CI, 6.8%-11.2%) reported doubling-up, 26.8% (95% CI,
23.1%-30.6%) reported unstable housing, and 6.5% (95% CI,
4.6%-8.5%) reported stable housing but previous homeless-
ness, totaling 43.6% (95% CI, 39.0%-48.1%) with any history
of housing problems. Compared with those without housing
problems, participants with housing problems were more likely
to report health problems, emergency department use, and de-
lays in care (Table). Twenty-nine percent (95% CI, 4.4%-
52.9%) of homeless, 1.1% (95% CI, 0%-2.2%) of doubled-up,
and 2.5% (95% CI, 0.8%-4.2%) of unstably housed patients
reported CHC assistance in finding a place to live.
Discussion | In this cross-sectional study, 43.6% of adult CHC
patients reported housing problems, including 1.2% who re-
ported current homelessness. By comparison, the point preva-
lence of homelessness in the US population has been esti-
mated at 0.18%.6 Limitations of this study include reliance
on cross-sectional self-report, the lack of a validated measure
of housing instability, and the potential lack of generalizabil-
ity to non-CHC clinic settings. Additionally, we did not exam-
ine the correlates of specific housing problems. Nonetheless,
the high prevalence of housing problems and their associa-
tion with adverse health metrics suggests that CHCs should
consider universal screening of housing status.
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Table. Characteristics of Patients With vs Without Housing Problems Among Patients at US Community Health Centers
Any Current or Prior Housing Problem (n = 1329) No Current or Prior Housing Problem (n = 1819)




18-44 554 54.2 (48.2-60.1) 676 52.0 (45.9-58.2)
45-64 663 38.4 (32.1-44.6) 835 33.4 (26.7-40.1)
≥65 112 7.5 (3.6-11.3) 308 14.6 (5.9-23.2)
Women 919 67.3 (63.1-71.5) 1277 64.0 (58.0-69.9) .30
Race/ethnicity
<.001
Non-Hispanic white 432 57.6 (50.1-65.1) 448 47.2 (39.0-55.4)
Non-Hispanic black 284 16.1 (11.7-20.5) 378 20.4 (14.4-26.4)
Non-Hispanic Asian 43 0.8 (0.2-1.3) 222 3.6 (0.7-6.5)
Non-Hispanic other 163 5.4 (2.9-7.9) 216 4.6 (2.6-6.7)
Hispanic 406 20.1 (14.2-26.0) 553 24.2 (17.4-30.9)
High school diploma 854 68.2 (62.4-73.9) 1101 65.2 (60.1-70.2) .28
Currently employed 432 35.4 (30.3-40.5) 713 41.9 (35.6-48.2) .07
Federal poverty level, %
<.001
≤100 859 60.1 (54.6-65.5) 919 50.9 (44.7-57.0)
101-199 359 31.5 (26.2-36.7) 580 28.4 (24.2-32.5)
≥200 102 8.4 (5.3-11.6) 307 20.8 (15.7-25.8)
Health insurance
<.001
None 265 29.7 (21.8-37.5) 337 24.2 (18.9-29.4)
Public 779 50.6 (43.4-57.8) 922 44.8 (39.7-49.9)
Private 262 19.4 (15.0-23.7) 559 30.1 (24.9-35.4)
Health Indicators
Fair or poor general health 697 44.8 (39.1-50.5) 786 37.6 (33.7-41.4) .04
Multiple chronic conditionsb 708 52.7 (46.9-58.5) 876 45.0 (40.1-50.0) .02
Functional impairmentc 236 17.6 (13.0-22.2) 185 9.1 (6.1-12.2) <.001
Sensory impairmentd 360 26.6 (21.3-31.8) 328 19.0 (14.4-23.5) .007
Fair or poor oral health 679 46.8 (42.1-51.6) 749 35.5 (31.3-39.8) .001
Serious mental illnesse 236 19.0 (14.1-23.8) 112 6.2 (3.7-8.7) <.001
High psychological distressf 265 22.2 (18.1-26.3) 153 7.5 (5.0-9.9) <.001
Lifetime drug useg 729 58.7 (51.8-65.5) 541 36.8 (29.9-43.6) <.001
Current alcohol use disorderg 122 10.8 (7.5-14.0) 84 3.6 (1.5-5.8) <.001
Current cigarette smoking 462 36.1 (30.1-42.1) 358 21.4 (15.4-27.5) <.001
Health Care Use and Access
Health service use
Emergency department use, past year 738 53.0 (47.2-58.9) 706 44.1 (39.5-48.7) .02
Hospitalization, past year 246 17.5 (13.1-22.0) 228 13.6 (11.0-16.3) .12
Medical care accessh
Delayed, past year 232 22.7 (16.8-28.6) 151 11.0 (7.6-14.4) <.001
Unmet need, past year 173 15.7 (10.1-21.4) 121 11.3 (7.3-15.4) .10
Prescription medication accessh
Delayed, past year 353 29.6 (22.2-36.9) 234 17.0 (12.7-21.3) <.001
Unmet need, past year 280 27.6 (21.5-33.7) 172 14.0 (10.1-18.0) <.001
a Two-tailed P values were obtained using the Rao-Scott χ2 test with strata,
cluster, and weight variables to account for the sampling design. P values for
multicategory variables reflect general tests of between-group differences
across all categories.
b 2 of asthma, cancer, kidney disease, chronic obstructive pulmonary disease,
diabetes, congestive heart failure, hepatitis B or C infection, HIV infection,
high cholesterol, hypertension, ischemic heart disease, or stroke.
c 1 of difficulty dressing or bathing, needing help with eating, getting in or out
of bed or chairs, or toileting.
d Serious difficulty hearing seeing (even with glasses).
e Diagnosis of schizophrenia or bipolar disorder.
f Score of 13 on the Kessler 6-item scale of psychological distress in the
past 30 d.
g Assessed with the WHO Alcohol, Smoking, and Substance Involvement
Screening Test (ASSIST).
h Participants needing past-year medical care (n = 2262); participants needing
past-year prescription medications (n = 2667); “delayed” indicates delay
in obtaining and “unmet need” indicates unable to obtain.
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COMMENT & RESPONSE
Organ Dysfunction After Surgery in Patients Treated
With Individualized or Standard Blood Pressure
Management
To the Editor In a randomized clinical trial,1 Dr Futier and col-
leagues assessed the effect of individualized vs standard blood
pressure management strategies on postoperative organ dys-
function. We had concerns regarding the blood pressure goals
that were established for the subgroup of patients that was as-
signed to the standard blood pressure group.
The authors chose to treat a systolic blood pressure (SBP)
less than 80 mm Hg or less than 40% from a patient’s resting
blood pressure. However, it has been well described in the lit-
erature and is standard practice to maintain the intraopera-
tive blood pressures within 20% of the patient’s best esti-
mate of preoperative blood pressure.2 Only in healthy patients
has a 25% to 35% decrease in blood pressure from immediate
preoperative baseline values been found acceptable.3 In a re-
cent analysis,4 maintaining intraoperative pressures below 20%
of preoperative values was associated with myocardial and kid-
ney injury. Thus, the authors’ decision to allow the blood pres-
sures to drop to less than 40% of preoperative values in the
standard group might have predisposed these patients to a
higher likelihood of postoperative organ dysfunction. The pa-
tient population studied by the authors had a high risk of peri-
operative complications and exposing these patients to a lower
blood pressure threshold than what is standard practice might
have artificially skewed the data in favor of the individual-
ized blood pressure group.
The other concern we had was that patients in the stan-
dard group received a higher volume of crystalloid adminis-
tration during surgery (2000 mL vs 1500 mL) compared with
the individualized blood pressure group. Administration of a
higher volume of fluids during the intraoperative period can
be associated with worse postoperative outcomes.5 The dif-
ference in fluid administration during the intraoperative pe-
riod between the 2 groups could also have affected the post-
operative outcomes.
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To the Editor Dr Futier and colleagues performed a study to
evaluate the effects of targeting perioperative blood pressure
based on patients’ individual preoperative blood pressures
compared with standard practice.1 However, methodological
issues raise questions about the results. The authors did not
simply compare 2 groups with different perioperative blood
pressure goals. Rather, they compared the outcomes of 2 com-
pletely different blood pressure management strategies.
First, the intervention group was managed with norepi-
nephrine infusions to achieve blood pressure goals, whereas
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